Cervical intraepithelial neoplasia grade 2/3
MONDO:0006137A neoplastic process in the cervix characterized by morphologic features of both moderate and severe intraepithelial neoplasia.
Also known as: CIN 2/3
38 clinical trials for this condition and its sub-types, 37 tagged with Cervical intraepithelial neoplasia grade 2/3 itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Heat therapy aims to burn away cervical precancer
Disease control By invitation onlyThis trial tests whether applying local heat to the cervix can clear high-risk HPV and treat early cervical precancerous lesions (CIN I and II). Women aged 18-65 with persistent high-risk HPV will receive heat therapy at 44°C for 30 minutes on several days. The study measures whe…
Sponsor: First Hospital of China Medical University • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Text and phone support helps cervical cancer survivors kick the habit
Disease control OngoingThis study tests whether a program combining phone counseling and personalized text messages can help 360 cervical cancer survivors in Florida quit smoking better than standard quitline services. Participants must have a history of cervical cancer or high-grade cervical dysplasia…
Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New study aims to find the best way to catch HPV cancers early in HIV patients
Diagnosis OngoingThis study looks at which tests work best to find early signs of HPV-related cancer in the cervix or anus of people living with HIV. About 1,586 participants from Mexico and Puerto Rico will be tested using different methods, including HPV tests and cell samples. The goal is to c…
Sponsor: University of California, San Francisco • Aim: Diagnosis
Last updated Aug 26, 2026 00:00 UTC
-
Can a simple HPV test replace colposcopy for cervical cancer Follow-Up?
Diagnosis OngoingThis study compares two ways to check for returning cervical pre-cancer after treatment: the standard colposcopy exam versus a high-risk HPV DNA test. Over 2,200 women who were treated for high-grade cervical lesions will be randomly assigned to one of the two follow-up methods. …
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Diagnosis
Last updated Jun 27, 2026 11:03 UTC
-
Cervical cancer screening showdown: pap vs. blood test study pulled
Diagnosis CancelledThis study was designed to compare the standard Pap smear with a new blood test that looks for three proteins linked to cervical cell changes. It planned to include adults aged 18-85 in good health. However, the study was withdrawn before enrolling any participants, so no results…
Sponsor: Timser SAPI de CV • Aim: Diagnosis
Last updated Jun 27, 2026 09:09 UTC